Are Softgels the Promised Land for Aurora Cannabis Stock?

It might not be the invention of the automobile or the electric light, but the Dec. 3 announcement by Aurora Cannabis (NYSE:ACB) that it has received the go-ahead from Health Canada to sell cannabis softgel capsules for both the Canadian medical and adult-use recreational markets, is excellent news for owners of ACB stock.

Following our successful receipt of our sales license for softgels, we are now ready to start providing yet another type of delivery technology for our patients and customers,” stated Shane Morris, Aurora’s SVP of product development and regulatory affairs.

“Production will be scaling up in the coming weeks, which will enable us to introduce this product to all our domestic and international target markets. We will also continue to develop new types of softgel products, broadening our offering to meet all medical and consumer needs.”

... read more at: